Chargement en cours...
A matched-control comparison of serious adverse events after intravitreal injections of bevacizumab for age-related macular degeneration and cataract extraction
PURPOSE: The study reported here investigated the rates of systemic serious adverse events (SAEs) following treatment with intravitreal bevacizumab for age-related macular degeneration (AMD) in comparison with a matched control group. METHODS: A retrospective age- and sex-matched case-control design...
Enregistré dans:
| Auteurs principaux: | , , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Dove Medical Press
2013
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3615876/ https://ncbi.nlm.nih.gov/pubmed/23569355 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OPTH.S42881 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|